NCT04567420
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04567420
Title DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE) (DARE)
Acronym DARE
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Criterium, Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85724 United States Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Intermountain Golden Colorado 80401 United States Details
Yale Cancer Center New Haven Connecticut 06510 United States Details
Winship Cancer Institute of Emory University Atlanta Georgia 30322 United States Details
Louisiana State University Health Sciences Center- New Orleans New Orleans Louisiana 70112 United States Details
Cancer Partners of Nebraska Lincoln Nebraska 68516 United States Details
New Mexico Cancer Care Alliance Albuquerque New Mexico 87131 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
Stony Brook University Cancer Center Stony Brook New York 11794 United States Details
The Ohio State University Wexner Medical Center James Cancer Hospital Columbus Ohio 43210 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
PRiSMs Group Laredo Texas 78041 United States Details
Virginia Cancer Institute Richmond Virginia 23229 United States Details
Swedish Cancer Institute Seattle Washington 98104 United States Details
University of Wisconsin Clinical Science Center Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field